<u>α-1 Antitrypsin:</u> In biology, the term "α-1 Antitrypsin" is also referred as "A1AT" and is determined as a serpin that consists of a major "protective effects" against the cigarette smoking and involves the development of emphysema, along with that the patients with the mutations of the "A1AT gene" tends to display an increased risk of emphysema development. However, It is mostly developed in people who are younger in age ranging from 30 to 40 years.
There are a number of different methods employed including clot-based coagulation tests, chromogenic assays, immunological tests, and aggregation studies. Today automated machines are designed to be able to perform a number of different methodologies.
